The market is experiencing positive growth due to a surge in various strategic initiatives undertaken by both public and private organizations. These initiatives encompass a range of activities such as product launches, mergers, acquisitions, regulatory approvals, and collaborations. This dynamic landscape is contributing to the market's expansion. One noteworthy example is Smith+Nephew (UK), which, in February 2022, introduced its advanced handheld robotics platform, the CORI Surgical System, in Japan. This next-generation robotic solution integrates 3-D intraoperative imaging with a precision milling tool, enabling surgeons to sculpt bone with enhanced precision while preserving anatomy in ligament sparing procedures. The CORI system digitally enhances surgeons' capabilities, allowing for individualized knee surgeries tailored to the patient's anatomy. This signifies a significant stride in advancing surgical procedures.
In another instance, Toyota Motor Corporation (Japan) launched the Welwalk WW-2000 in November 2019, a robot designed to provide rehabilitation support for individuals with lower limb paralysis resulting from conditions like stroke. The upgraded version, Welwalk WW-2000, improves upon its predecessor by displaying real-time assistance settings and introducing a game function to boost patient motivation during rehabilitation. The incorporation of new features in this model reduces the workload on therapists compared to the previous version, offering more efficient walking training for patients. Further contributing to market dynamics, Medtronic (US) made a strategic move in February 2020 by acquiring Digital Surgery (UK). This acquisition integrated Digital Surgery into Medtronic's surgical robotics business, part of their minimally invasive therapies group. The integration is expected to broaden patients' access to high-quality medical care, showcasing the collaborative nature of industry players.
In January 2021, Freehand (US) announced a strategic partnership with Imperial Medical Solutions (IMS) (UK), a clinician-led healthcare consultancy. This collaboration aims to support the adoption of Freehand's surgical robots by hospitals in India, Sri Lanka, Malaysia, and the Caribbean, underscoring the global impact of these technological advancements.Adding to the roster of achievements, Renishaw (UK) declared in May 2022 that its neuromate stereotactic robot, equipped with neuroinspire surgical planning software, received EU Medical Device Regulation (MDR) certification from the British Standards Institution (BSI), its Notified Body. This certification further establishes the credibility and compliance of Renishaw's technology within the regulatory framework. Collectively, these strategic initiatives reflect the diverse and collaborative efforts fueling the positive trajectory of the market.
Report Attribute/Metric | Details |
---|---|
Segment Outlook | Type, Product, Application, Setting, End User, and Region |
Medical Robotics Market size was valued at USD 11.67 billion in 2022. The Medical Robotics Market industry is projected to grow from USD 13.19 billion in 2024 to USD 52.41 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 15.69% during the forecast period (2024 - 2032).
Growing applications of medical robotics is one of the major factors driving the growth of the Medical Robotics Market. Likewise, technological advancements and increasing strategic initiatives are further fueling the growth of the global market during the review period.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Surgical robotics has emerged as a new growth point and technological incubator in modern surgery. Robot-assisted surgeries were developed to augment the capabilities of surgeons while performing open surgeries on a patient or to address the limits of existing minimally invasive surgery technologies. Minimally invasive surgery with surgical robotics aids in reducing recovery time, accelerating healing, and in avoiding scarring. The increased need for minimally invasive surgical treatments, as well as the use of medical robotics in helping surgical procedures, have significantly improved the efficacy of surgical operations. Therefore, the above-mentioned factors are promoting market growth.
Furthermore, the number of prescriptions filled for American adults and children rose by 85%, from 2.4 billion to 4.5 billion a year, between 1997 and 2016. The rising incidence of medication errors, particularly dispensing errors in hospitals and retail pharmacies, is a burden on pharmacists and driving demand for medical robotics for automating the dispensing process. According to the data published by Enliven Health in July 2020, medication errors harm at least 1.5 million people, and around 7,000-9,000 people die due to medication errors per year in the US.
The Medical Robotics Market segmentation, based on type, includes equipment, service, and consumables. The equipment segment held the majority share in the market in 2022. The fundamental modules in equipment generally comprise a controller unit and a manipulator. The manipulator is usually in the form of a robot arm that is designed to perform actions and consists of jointed segments, sensors, a drive system, and an effector. Procuring equipment generally consists of complete robotic systems and is generally capital-intensive. The equipment goes through rigorous regulatory checks and clinical trials. Only after receiving market authorizations do such products enter into the commercial market.
The Medical Robotics Market segmentation, based on product, includes surgical robots, rehabilitation robots, noninvasive radiosurgery robots, hospital & pharmacy robots, emergency response robotic systems, logistics/handling robotic systems, imaging robotic systems. The rehabilitation robots segment dominated the market in 2022. The surgical robots segment is further divided into soft tissue surgery, hard tissue surgery, and microsurgery.
Furthermore, the rehabilitation robots segment is further divided into assistive robots, prosthetics, orthotics, therapeutic robots, and exoskeleton robotic systems. Moreover, the hospital and pharmacy robots are further divided into telemedicine robots, I.V. robots, pharmacy robots, and cart transportation robots. Rehabilitation robots augment patient rehabilitation through the application of robotic devices. These robots allows patients to practice movements aided by the robot. In recent years, there has been a rapid and vast development of robots for the rehabilitation of sensorimotor deficits after damage to the central nervous system (CNS). For instance, in December 2021, Inrobics Social Robotics launched an AI-based robotic device to improve health rehabilitation. Further, in November 2019, Toyota Motor Corporation (Toyota) launched the new Welwalk WW-2000, a robot designed to provide rehabilitation support to individuals with lower limb paralysis as a result of stroke and other causes. In addition, current advancements in rehabilitation processes, methodologies, tools, and the rapid incorporation of AI are expected to increase the market for rehabilitation robots.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Based on application, the global medical robotics industry has been segmented into neurology, oncology, orthopedic, laparoscopy, cardiology, aesthetic surgery, rehabilitation, angiography, and others. The oncology segment is further divided into breast cancer, intraoperative radiation therapy, and others. Moreover, the orthopedic segment is further bifurcated into non-contact bone cutting and bone surgery and others.
The laparoscopy segment held the largest market share in 2022. Laparoscopic devices are proved to be effective tools for diagnostic and therapeutic purposes. The rise in funding and reimbursement framework has been observed in laparoscopy-assisted surgeries. There has been an increasing adoption of robot-assisted laparoscopy procedures in recent times. The demand for robot-assisted minimally invasive surgery is increasing due to the significant benefits associated with laparoscopic surgical procedures, such as small or no incision, short hospital stays, less pain, quick recovery time, less wounds, and reduced blood loss.
The Medical Robotics Market segmentation, based on setting, includes homecare, in-patient, and out-patient. The out-patient segment dominated the market in 2022. There’s increasing adoption of surgical robotics in outpatient settings owing to its several benefits such as immediate treatment.
The Medical Robotics Market segmentation, based on end user, includes hospital & clinics, specialty centers, rehabilitation centers, and others. The hospital & clinics segment dominated the market in 2022. This is because hospitals and clinics provide patients with all types of treatment options and consultations in a single visit. The market growth of hospitals & clinics is due to the increasing number of hospitals and the rising number of surgeries. The hospitals & clinics segment is attributed to the growing adoption of medical robotics for various applications including surgery, I.V. preparations, sterilization, logistics, diagnostics, and more.
By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. The North America medical robotics market accounted for the largest market share in 2022. Key factors attributed to it are the increasing efficiency of medical robots in performing tasks that include surgeries in the geriatric population and mounting cases of trauma injuries are some of the major factors driving the growth of the medical robotics market in the region.
Further, the major countries will be study are: The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: MEDICAL ROBOTICS MARKET BY REGION 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe medical robotics market accounted for the second-largest market share due to increasing geriatric population in the developed countries and the globalization of healthcare. Furthermore, the Germany medical robotics market attributed to hold the largest market share, and the France medical robotics market is projected be the fastest growing market in the Europe region.
The Asia-Pacific medical robotics market is expected to be the fastest growing from 2024 to 2032 due to the rising geriatric population and the rise in the demand for minimally invasive and non-invasive surgical procedures. rising geriatric population and the rise in the demand for minimally invasive and non-invasive surgical procedures. Moreover, China medical robotics market accounted to hold the largest market share, and the India medical robotics market is projected to be the fastest growing market in the Asia-Pacific region.
Medical Robotics Key Market Players & Competitive Insights
Despite several market drivers having a significant impact on market growth, the growth projectile of market players is dependent on market conditions, government assistance, and industry development. However, the market is highly competitive, with well-established companies, well-defined market entry channels, and a robust product innovation pipeline. Several industry participants are introducing products to differentiate themselves in this competitive market.
Auris Health Inc. (Auris) is a leading company that develops minimally invasive techniques. Moreover, the company transforms medical intervention by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform. Additionally, Auris Health was acquired by Ethicon (a subsidiary of Johnson & Johnson Services, Inc.) in 2019 to expand its digital surgery portfolio. The company has a global presence in more than 170 countries worldwide.
Moreover, In May 2022, Ethicon's monarch received FDA approval for urology procedures. Initially, the monarch was only used for bronchoscopy.
Key Companies in the medical robotics market includes.
Medical Robotics Industry Developments
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)